beleodaq.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Beleodaq® |
| Description | In the next round against relapsed or refractory PTCL, fight on with Beleodaq®. It is an HDAC inhibitor available for relapsed/refractory |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 74.220.203.200 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
beleodaq.com Valuation
|
US$3,514,488
Last updated: 2023-05-09 05:18:01
beleodaq.com has Semrush global rank of 3,011,621. beleodaq.com has an estimated worth of US$ 3,514,488, based on its estimated Ads revenue. beleodaq.com receives approximately 405,518 unique visitors each day. Its web server is located in United States, with IP address 74.220.203.200. According to SiteAdvisor, beleodaq.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$3,514,488 |
| Daily Ads Revenue | US$3,245 |
| Monthly Ads Revenue | US$97,325 |
| Yearly Ads Revenue | US$1,167,892 |
| Daily Unique Visitors | 27,035 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| beleodaq.com. | A | 7199 | IP: 74.220.203.200 |
| beleodaq.com. | NS | 86400 | NS Record: ns2.hostmonster.com. |
| beleodaq.com. | NS | 86400 | NS Record: ns1.hostmonster.com. |
| beleodaq.com. | MX | 14400 | MX Record: 0 mail.beleodaq.com. |
| beleodaq.com. | TXT | 14400 | TXT Record: v=spf1 +a +mx +ip4:67.20.116.98 +ip4:74.220.203.200 +include:hostmonster.com ~all |
HtmlToTextCheckTime:2023-05-09 05:18:01
| Approved Use 1 Beleodaq ® (belinostat) is a prescription medicine used to treat people with a type of cancer called peripheral T-cell lymphoma (PTCL) that comes back or does not respond to previous treatment. This indication is approved under accelerated approval based on tumor response rate and duration of response. An improvement in survival or disease-related symptoms has not been established. Continued approval for this indication may be contingent upon verification and description of clinical benefit in the confirmatory trial. It is not known if Beleodaq ® is safe and effective in children. Intended for U.S. Audiences Only Important Safety Information Prescribing Information Approved Use U.S. Healthcare Providers About Beleodaq ® Taking Beleodaq ® How Beleodaq ® May Help Side Effects Support & Resources About Beleodaq ® Taking Beleodaq ® How Beleodaq ® May Help Side Effects Support & Resources Beleodaq ® Patient Important Safety Information See More See Less What Is Beleodaq ® ? |
HTTP Headers
HTTP/1.1 403 Forbidden Date: Sun, 31 Oct 2021 08:02:45 GMT Server: nginx/1.19.10 Content-Type: text/html; charset=iso-8859-1 Content-Length: 318 |
beleodaq.com Whois Information
Domain Name: BELEODAQ.COM Registry Domain ID: 1832464176_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.fastdomain.com Registrar URL: http://www.fastdomain.com Updated Date: 2020-10-10T15:40:56Z Creation Date: 2013-10-25T11:40:36Z Registry Expiry Date: 2021-10-25T11:40:36Z Registrar: FastDomain Inc. Registrar IANA ID: 1154 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.HOSTMONSTER.COM Name Server: NS2.HOSTMONSTER.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-18T18:00:00Z <<< |